CD4 and neoplasm: However, despite demonstrating similar CD4+ mediated GVHD, the allorecipients of SDHA-KO and WT cells still demonstrated similar tumor-related mortality (Figure 5C), demonstrating similar magnitude of preservation of CD8+ T cell–mediated GVT effects after allo-HCT (Figure 5D).